Functional interactions of human immunodeficiency virus type 1 integrase with human and yeast HSP60

被引:44
|
作者
Parissi, V
Calmels, C
De Soultrait, VR
Caumont, A
Fournier, M
Chaignepain, S
Litvak, S
机构
[1] Univ Bordeaux 2, REGER, CNRS, UMR 5097, F-33076 Bordeaux, France
[2] Hop Pellegrin, Virol Lab, F-33076 Bordeaux, France
[3] IBGC, CNRS, Bordeaux, France
[4] IFR66 Pathol Infect, Bordeaux, France
关键词
D O I
10.1128/JVI.75.23.11344-11353.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Integration of human immunodeficiency virus type 1 (HIV-1) proviral DNA in the nuclear genome is catalyzed by the retroviral integrase (IN). In addition to IN, viral and cellular proteins associated in the high-molecular-weight preintegration complex have been suggested to be involved in this process. In an attempt to define host factors interacting with IN, we used an in vitro system to identify cellular proteins in interaction with HIV-1 IN. The yeast Saccharomyces cerevisiae was chosen since (i) its complete sequence has been established and the primary structure of all the putative proteins from this eucaryote has been deduced, (ii) there is a significant degree of homology between human and yeast proteins, and (iii) we have previously shown that the expression of HIV-1 IN in yeast induces a lethal phenotype. Strong evidences suggest that this lethality is linked to IN activity in infected human cells where integration requires the cleavage of genomic DNA. Using IN-affinity chromatography we identified four yeast proteins interacting with HIV-1 IN, including the yeast chaperonin yHSP60, which is the counterpart of human hHSP60. Yeast lethality induced by HIV-1 IN was abolished when a mutated HSP60 was coexpressed, therefore suggesting that both proteins interact in vivo. Besides interacting with HIV-1 IN, the hHSP60 was able to stimulate the in vitro processing and joining activities of IN and protected this enzyme from thermal denaturation. In addition, the functional human HSP60-HSP10 complex in the presence of ATP was able to recognize the HIV-1 IN as a substrate.
引用
收藏
页码:11344 / 11353
页数:10
相关论文
共 50 条
  • [11] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE MUTANTS
    ANSARILARI, MA
    DONEHOWER, LA
    GIBBS, RA
    VIROLOGY, 1995, 211 (01) : 332 - 335
  • [12] Characterization of Recombinant Integrase of Human Immunodeficiency Virus Type 1 (Isolate Bru)
    E. A. Semenova
    N. M. Gashnikova
    T. V. Il'ina
    T. R. Pronyaeva
    A. G. Pokrovsky
    Biochemistry (Moscow), 2003, 68 : 988 - 993
  • [13] Role of Human Immunodeficiency Virus Type 1 Integrase in Uncoating of the Viral Core
    Briones, Marisa S.
    Dobard, Charles W.
    Chow, Samson A.
    JOURNAL OF VIROLOGY, 2010, 84 (10) : 5181 - 5190
  • [14] GENETIC-ANALYSIS OF HOMOMERIC INTERACTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE USING THE YEAST 2-HYBRID SYSTEM
    KALPANA, GV
    GOFF, SP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) : 10593 - 10597
  • [15] Inhibitors of human immunodeficiency virus integrase
    Pommier, Y
    Neamati, N
    ADVANCES IN VIRUS RESEARCH, VOL 52, 1999, 52 : 427 - 458
  • [16] Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase Inhibitors
    Low, Andrea
    Prada, Nicole
    Topper, Michael
    Vaida, Florin
    Castor, Delivette
    Mohri, Hiroshi
    Hazuda, Daria
    Muesing, Mark
    Markowitz, Martin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4275 - 4282
  • [17] Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1
    Liu, HM
    Wu, XY
    Xiao, HL
    Kappes, JC
    JOURNAL OF VIROLOGY, 1999, 73 (10) : 8831 - 8836
  • [18] A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase
    de Soultrait, VR
    Caumont, A
    Parissi, V
    Morellet, N
    Ventura, M
    Lenoir, C
    Litvak, S
    Fournier, M
    Roques, B
    JOURNAL OF MOLECULAR BIOLOGY, 2002, 318 (01) : 45 - 58
  • [19] Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase
    McDougall, B
    King, PJ
    Wu, BW
    Hostomsky, Z
    Reinecke, MG
    Robinson, WE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) : 140 - 146
  • [20] (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase
    Eich, E
    Pertz, H
    Kaloga, M
    Schulz, J
    Fesen, MR
    Mazumder, A
    Pommier, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 86 - 95